80 related articles for article (PubMed ID: 8929456)
1. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
3. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Liu D; Liu T; Sy MS
Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
[TBL] [Abstract][Full Text] [Related]
4. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
6. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
Liu D; Sy MS
J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
[TBL] [Abstract][Full Text] [Related]
8. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
10. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.
Liu D; Sy MS
J Exp Med; 1996 May; 183(5):1987-94. PubMed ID: 8642309
[TBL] [Abstract][Full Text] [Related]
11. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.
Lesley J; English N; Charles C; Hyman R
Eur J Immunol; 2000 Jan; 30(1):245-53. PubMed ID: 10602047
[TBL] [Abstract][Full Text] [Related]
12. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
Levesque MC; Haynes BF
Cell Immunol; 1999 May; 193(2):209-18. PubMed ID: 10222064
[TBL] [Abstract][Full Text] [Related]
13. Requirements for signal delivery through CD44: analysis using CD44-Fas chimeric proteins.
Ishiwatari-Hayasaka H; Fujimoto T; Osawa T; Hirama T; Toyama-Sorimachi N; Miyasaka M
J Immunol; 1999 Aug; 163(3):1258-64. PubMed ID: 10415022
[TBL] [Abstract][Full Text] [Related]
14. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Zhu D; Bourguignon LY
Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
16. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
17. Adhesion of lymphoid cells to CD44-specific substrata: the consequences of attachment depend on the ligand.
Kim JH; Glant TT; Lesley J; Hyman R; Mikecz K
Exp Cell Res; 2000 May; 256(2):445-53. PubMed ID: 10772817
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells.
Brown KL; Birkenhead D; Lai JC; Li L; Li R; Johnson P
Exp Cell Res; 2005 Feb; 303(2):400-14. PubMed ID: 15652352
[TBL] [Abstract][Full Text] [Related]
19. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
Lesley J; Kincade PW; Hyman R
Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
